Group | E2 (pg/mL) | FSH (IU/L) | LH (pg/mL) | PRL (pg/mL) | PG (pg/mL) | ACTH (pg/mL) |
---|---|---|---|---|---|---|
Control | 60.63 ± 12.18 | 22.38 ± 3.79 | 33.19 ± 6.06 | 729.7 ± 79.8 | 369.6 ± 25.2 | 108.4 ± 16.0 |
ART low-dose | 64.15 ± 7.54 | 20.71 ± 4.27 | 33.82 ± 4.62 | 746.3 ± 63.5 | 345.8 ± 57.2 | 111.3 ± 18.1 |
ART mid-dose | 65.07 ± 4.53 | 21.40 ± 3.59 | 35.11 ± 4.26 | 740.6 ± 47.9 | 352.9 ± 27.5 | 108.1 ± 14.5 |
ART high-dose | 65.65 ± 4.84 | 21.08 ± 2.48 | 34.55 ± 5.24 | 710.1 ± 68.5 | 357.6 ± 36.0 | 115.5 ± 17.7 |
PQ low-dose | 63.13 ± 9.56 | 20.28 ± 1.79 | 29.53 ± 6.87 | 660.2 ± 50.1 | 323.4 ± 44.1* | 129.0 ± 13.5* |
PQ mid-dose | 62.14 ± 6.76 | 23.04 ± 2.75 | 31.98 ± 7.61 | 674.9 ± 85.6 | 319.2 ± 41.5* | 127.3 ± 8.4* |
PQ high-dose | 70.81 ± 11.87 | 22.12 ± 2.81 | 29.73 ± 7.27 | 708.1 ± 68.3 | 313.3 ± 23.3* | 132.6 ± 16.4* |
ATQ low-dose | 55.46 ± 11.46 | 21.31 ± 2.43 | 32.93 ± 11.75 | 634.4 ± 46.8* | 308.6 ± 52.8* | 131.8 ± 35.9* |
ATQ mid-dose | 61.66 ± 9.57 | 21.35 ± 3.32 | 33.24 ± 12.89 | 637.3 ± 91.8* | 302.1 ± 29.0* | 129.5 ± 16.4* |
ATQ high-dose | 54.19 ± 10.22 | 19.30 ± 3.47 | 29.34 ± 5.26 | 595.8 ± 51.9* | 293.9 ± 60.8* | 141.0 ± 17.1* |